Lantern Pharma Inc. (LTRN)
Market Closed
12 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 60
-0.14
-3.74%
$
42.5M Market Cap
- P/E Ratio
0% Div Yield
25,005 Volume
-2.03 Eps
$ 3.74
Previous Close Day Range
3.59 3.78
Year Range
2.55 6.12
Want to track LTRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| LTRN Lantern Pharma Inc. 13 Nov 2025 | | - | - |
| LTRN Lantern Pharma Inc. 6 Nov 2025 | | - | - |
| LTRN Lantern Pharma Inc. 5 Nov 2025 | | - | - |
| LTRN Lantern Pharma Inc. 6 Aug 2025 | | - | - |
| LTRN Lantern Pharma Inc. 7 May 2025 | | - | - |
| LTRN Lantern Pharma Inc. 17 Mar 2025 | | - | - |
| LTRN Lantern Pharma Inc. 6 Nov 2024 | | - | - |
| LTRN Lantern Pharma Inc. 7 Aug 2024 | | - | - |
| LTRN Lantern Pharma Inc. 9 May 2024 | | - | - |
| LTRN Lantern Pharma Inc. 18 Mar 2024 | | - | - |
| LTRN Lantern Pharma Inc. 6 Nov 2023 | | - | - |
LTRN Earnings Reports FAQ
What is the earnings per share (EPS) for LTRN?
The current EPS is -2.03.
What is the company's earnings growth rate?
Lantern Pharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Lantern Pharma Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lantern Pharma Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LTRN at this time, as Lantern Pharma Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
